Password reminder
Vascular News
Contact the editor Visit Vascular News Twitter feed Visit Vascular News Facebook page

Mechanochemical ablation shows 96% closure rate at two years

Friday, 08 Jun 2012 14:29
Steve Elias
Steve Elias

At two years, mechanochemical ablation (MOCA) is as efficacious as current endothermal techniques without the need of tumescent anaesthesia and is more effective than reported results of foam sclerotherapy of the great saphenous vein. Steve Elias, who presented the first-in-man two-year results with the technique at the Vascular Annual Meeting (Washington DC, USA,7–9 June 2012), said that MOCA is another alternative modality for most incompetent great and small saphenous veins.

Elias, director, Division of Vascular Surgery Vein Programs, Columbia University and Medical Center, New York, USA, told delegates that the mechanochemical ablation catheter (ClariVein, Vascular Insights) utilises a liquid sclerosant (sodium tetradecyl sulfate or aethoxysclerol) and a mechanical rotating wire to accomplish occlusion of incompetent great or small saphenous vein. The procedure does not require tumescence and is performed with local anaesthesia at the access site only. It can be characterised as mechanically enhanced sclerotherapy performed in an office setting.

Thirty great saphenous veins in 29 patients underwent micropuncture access with local anaesthesia only in this first-in-man study. Through a 5F micropuncture sheath the MOCA catheter was passed to a position 2cm from the saphenofemoral junction. Catheter wire rotation was begun for 3 seconds at 3,500rpm. With the wire rotating, infusion of sclerosant (1.5% sodium tetradecyl sulfate) and catheter pullback (1.5mm/sec) was begun simultaneously. A total of 12cc of sclerosant was used for each great saphenous vein. The procedure does not require the instillation of tumescent aneasthesia.

At one year, 29 of 30 great saphenous veins were successfully treated. Primary closure rate 96%. At two years, 24 patients were examined. All 24 remain closed. No deep vein thrombosis, nerve or skin injury occurred. Average total procedure time was 14 minutes. Catheter treatment time was five minutes. The MOCA technique has been modified; lower volumes are now used based on diameter and length of vein treated. Catheter placement is closer to saphenofemoral junction (1cm).

Elias said that 6,000 cases have been treated with MOCA worldwide, with >90% occlusion rate. Quality of life was improved as with any successful endovenous ablation intervention. Deep vein thrombosis rate was below 1% and there was no nerve/skin injury. Elias also told delegates what we have learned about the technique: “Rotate first (spasm/vortex) then inject slow. Catheter on is catheter moving. It is a two-handed technique, one pulls and one injects.

The tendency is to pull too fast and to inject too slow.” About volume, he said, that it originally was 12cc (1.5% STD) for all. Now, he added, volume is based on diameter/length and tends to be less. On concentration, he said that stronger is better.

Elias summarised his presentation saying that MOCA works and is safe, with a learning curve of five to eight cases. It does not involve the use of tumescence anaesthesia and is another good option for ablation.

Add New Comment

Related Items

Most popular

First drug-eluting balloon approved in USA
Friday, 10 Oct 2014
The FDA has approved the Lutonix drug-eluting balloon for the management of peripheral artery disease. This is the first time that the agency has approved such a device for this indication in the USA. First drug-eluting balloon approved in USA

Thursday, 25 Sep 2014
Operators should be aware of radiation exposure to the head increasing with angulation of the C-arm and limit this manoeuvre, according to a study presented at the ESVS Annual Meeting. C-arm angulation increases radiation exposure to the head during complex EVAR

Bioresorbable scaffolds can produce comparable acute results to metal stents
Tuesday, 04 Nov 2014
Speaking at the Asian Society for Vascular Surgery meeting (5–7 September, Hong Kong, China), Andrew Holden commented that studies indicate that bioresorbable scaffolds can produce comparable acute ... Bioresorbable scaffolds can produce comparable acute results to metal stents


A new classification system for acute type B aortic dissection predicting reverse aortic remodelling
Wednesday, 19 Nov 2014
In recent years, primary stent grafting for complicated type B aortic dissection has been applied with favourable results. Thoracic aortic endovascular repair can be offered with a relatively low ... A new classification system for acute type B aortic dissection predicting reverse aortic remodelling

Resolving differences between carotid stenosis management guidelines
Wednesday, 19 Nov 2014
Anne Abbott, Melbroune, Australia, writes that while some variability in guideline recommendations is due to different publication dates, much is due to bias in what evidence is considered and how it ... Resolving differences between carotid stenosis management guidelines


Martin Björck
Wednesday, 01 Oct 2014
Martin Björck, Uppsala University Hospital, Sweden, holds the only professor-chair of vascular ... Martin Björck

Cliff Shearman
Thursday, 03 Jul 2014
A former president of the Vascular Society of Great Britain and Ireland, Cliff Shearman was ... Cliff Shearman

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions